Evolution of Lantibiotic Salivaricins: New Weapons to Fight Infectious Diseases

Trends Microbiol. 2020 Jul;28(7):578-593. doi: 10.1016/j.tim.2020.03.001. Epub 2020 Apr 6.

Abstract

Lantibiotic salivaricins are polycyclic peptides containing lanthionine and/or β-methyllanthionine residues produced by certain strains of Streptococcus salivarius, which almost exclusively reside in the human oral cavity. The importance of these molecules stems from their antimicrobial activity towards relevant oral pathogens which has so far been applied through the development of salivaricin-producing probiotic strains. However, salivaricins may also prove to be of great value in the development of new and novel antibacterial therapies in this era of emerging antibiotic resistance. In this review, we describe the biosynthesis, antimicrobial activity, structure, and mode of action of the lantibiotic salivaricins characterized to date. Moreover, we also provide an expert opinion and suggestions for future development of this important field of microbiology.

Keywords: Streptococcus salivarius; antibiotic resistance; bacteriocins; lantibiotics; probiotics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amino Acid Sequence
  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / metabolism
  • Bacterial Proteins / pharmacology
  • Bacteriocins / metabolism*
  • Bacteriocins / pharmacology
  • Humans
  • Microbial Sensitivity Tests
  • Mouth / microbiology
  • Probiotics / metabolism
  • Sequence Alignment
  • Streptococcus salivarius / metabolism*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Bacteriocins
  • salivaricin A